SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-054518
Filing Date
2021-11-04
Accepted
2021-11-04 16:31:11
Documents
46
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mack-10q_20210930.htm   iXBRL 10-Q 967945
2 EX-31.1 mack-ex311_8.htm EX-31.1 9571
3 EX-31.2 mack-ex312_7.htm EX-31.2 9572
4 EX-32.1 mack-ex321_6.htm EX-32.1 5726
5 EX-32.2 mack-ex322_9.htm EX-32.2 5726
  Complete submission text file 0001564590-21-054518.txt   3177928

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mack-20210930.xsd EX-101.SCH 28322
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mack-20210930_cal.xml EX-101.CAL 20560
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mack-20210930_def.xml EX-101.DEF 63159
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20210930_lab.xml EX-101.LAB 200428
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20210930_pre.xml EX-101.PRE 141688
11 EXTRACTED XBRL INSTANCE DOCUMENT mack-10q_20210930_htm.xml XML 417866
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35409 | Film No.: 211380466
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences